{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:07Z","timestamp":1787729467393,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dadr.2024.100241","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:24:28Z","timestamp":1715041468000},"page":"100241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods"],"prefix":"10.1016","volume":"11","author":[{"given":"Erin","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merci","family":"Ujeneza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Badea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.dadr.2024.100241_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100241_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108321","article-title":"Opioid-related overdose mortality in the era of fentanyl: monitoring a shifting epidemic by person, place, and time","volume":"216","author":"Althoff","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100241_bib3","first-page":"892","article-title":"Xylazine poisoning: a systematic review","volume":"Vol. 60","author":"Ball","year":"2022"},{"issue":"3","key":"10.1016\/j.dadr.2024.100241_bib4","first-page":"176","article-title":"What is drug checking, anyway?","volume":"23","author":"Barratt","year":"2022","journal-title":"Drugs\u00a0Habits Soc. Policy"},{"key":"10.1016\/j.dadr.2024.100241_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/00952990.2023.2226312","article-title":"Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies","author":"Bhuiyan","year":"2023","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.dadr.2024.100241_bib6","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: A lesser-known entity","volume":"89","author":"Bishnoi","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.dadr.2024.100241_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111028","article-title":"Costing analysis of a point-of-care drug checking program in Rhode Island","volume":"253","author":"Cepeda","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100241_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104118","article-title":"Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island","volume":"118","author":"Collins","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.dadr.2024.100241_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-023-00905-8","article-title":"First drug-checking study at an electronic festival and fentanyl detection in the central region of Mexico","volume":"20","author":"Cruz","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.dadr.2024.100241_bib10","unstructured":"Drug Enforcement Administration, 2022. DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine. DEA Public Safety Alert. \u3008https:\/\/www.dea.gov\/alert\/dea-reports-widespread-threat-fentanyl-mixed-xylazine\u3009."},{"key":"10.1016\/j.dadr.2024.100241_bib11","doi-asserted-by":"crossref","unstructured":"Evans, W.N., Lieber, E., Power, P., 2018. How the Reformulation of OxyContin Ignited the Heroin Epidemic. \u3008https:\/\/wondercdc.gov\/controller\/datarequest\/D77\u3009.","DOI":"10.3386\/w24475"},{"key":"10.1016\/j.dadr.2024.100241_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.dadr.2024.100241_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-023-00764-3","article-title":"Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations","volume":"20","author":"Gozdzialski","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.dadr.2024.100241_bib14","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1097\/PHH.0000000000001581","article-title":"Implementation and uptake of the massachusetts drug supply data stream: a statewide public health-public safety partnership drug checking program","volume":"28","author":"Green","year":"2022","journal-title":"J. Public Health Manag. Pract."},{"issue":"4","key":"10.1016\/j.dadr.2024.100241_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine \u2013 a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene","year":"1988","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.dadr.2024.100241_bib16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine \u2014 medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100241_bib17","first-page":"896","article-title":"Lot-to-lot variations in a qualitative lateral-flow immunoassay for chronic pain drug monitoring","volume":"Vol. 60","author":"Hayden","year":"2014"},{"issue":"48","key":"10.1016\/j.dadr.2024.100241_bib18","article-title":"Xylazine (\u201ctranq\u201d): the potential for loss of life and limb","volume":"4","author":"Haymann","year":"2022","journal-title":"Dermatol. World Insights Inq."},{"issue":"26","key":"10.1016\/j.dadr.2024.100241_bib19","article-title":"Illicitly manufactured fentanyl\u2013involved overdose deaths with detected xylazine \u2014 United States, January 2019\u2013June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2024.100241_bib20","series-title":"Evaluation of BTNX Xylazine Test Strips for Drug Checking","author":"Krotulski","year":"2023"},{"key":"10.1016\/j.dadr.2024.100241_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103196","article-title":"Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs","volume":"94","author":"Park","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100241_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109610","article-title":"Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples","volume":"240","author":"Park","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100241_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104206","article-title":"A survey of North American drug checking services operating in 2022","volume":"121","author":"Park","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100241_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100241_bib25","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend. Rep."},{"issue":"4","key":"10.1016\/j.dadr.2024.100241_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/02791072.1986.10472371","article-title":"MDMA on the street: analysis anonymous\u00ae","volume":"18","author":"Renfroe","year":"1986","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.dadr.2024.100241_bib27","first-page":"1","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"Vol. 240","author":"Ruiz-Col\u00f3n","year":"2014"},{"key":"10.1016\/j.dadr.2024.100241_bib28","doi-asserted-by":"crossref","unstructured":"Sisco, E., Nestadt, D.F., Bloom, M.B., Schneider, K.E., Elkasabany, R.A., Rouhani, S., Sherman, S.G., 2023. Xylazine Test Strips For Drug Checking Understanding Sensitivity and Cross-Reactivity of Xylazine Lateral Flow Immunoassay Test Strips for Drug Checking Applications Xylazine test strips for drug checking.\u00a0https:\/\/doi.org\/10.26434\/chemrxiv-2023-znb8j-v2.","DOI":"10.26434\/chemrxiv-2023-znb8j-v2"},{"issue":"6","key":"10.1016\/j.dadr.2024.100241_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of reddit subscribers","volume":"17","author":"Spadaro","year":"2023","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.dadr.2024.100241_bib30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1373\/clinchem.2015.241315","article-title":"Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening","volume":"62","author":"Thoren","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.dadr.2024.100241_bib31","series-title":"World Drug Report 2022","author":"United Nations Office on Drugs and Crime & Division for Treaty Affairs","year":"2022"},{"key":"10.1016\/j.dadr.2024.100241_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122904","article-title":"Illicit drugs street samples and their cutting agents. The result of the GC-MS based profiling define the guidelines for sensors development","volume":"237","author":"\u017bubrycka","year":"2022","journal-title":"Talanta"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:13:55Z","timestamp":1718867635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S2772724624000258"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100241","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100241"}}